TSX:CURAPharmaceuticals
Is Curaleaf (TSX:CURA) Using Spain’s New Cannabis Rules To Recast Its Global Pharma Ambitions?
Curaleaf Holdings’ Spanish subsidiary recently received approval from Spain’s medicines regulator to register two standardized cannabis preparations for prescription use in hospital pharmacies under Royal Decree 903/2025.
By becoming the first company to secure such registrations under Spain’s new framework, Curaleaf has opened an early-mover pathway in Europe for pharmaceutical-grade cannabis formulations.
We’ll now examine how Curaleaf’s first-mover regulatory approval in Spain could...